Krishna bajjuri
Sr Director Sutro Biopharma
Seminars
Wednesday 5th November 2025
Specific Dual Payload ADCs: Developing Novel β-Glucuronidase Cleavable Linker Payloads to Overcome Resistance Mechanisms
11:00 am
- Leveraging a cutting-edge cell-free system to develop novel dual payload ADCs
- Showcasing the synergetic efficacy of Top1i combined with diverse MoA payloads to overcome the resistance
- Enhancing preclinical efficacy in both in vitro and in vivo models with dual payload ADCs
